BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25351971)

  • 1. Price elasticity and medication use: cost sharing across multiple clinical conditions.
    Gatwood J; Gibson TB; Chernew ME; Farr AM; Vogtmann E; Fendrick AM
    J Manag Care Spec Pharm; 2014 Nov; 20(11):1102-7. PubMed ID: 25351971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Price elasticity of demand for buprenorphine/naloxone prescriptions.
    McClellan C; Fingar KR; Ali MM; Olesiuk WJ; Mutter R; Gibson TB
    J Subst Abuse Treat; 2019 Nov; 106():4-11. PubMed ID: 31540610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.
    Cecil WT; Barnes J; Shea T; Coulter SL
    J Manag Care Pharm; 2006 Oct; 12(8):665-76. PubMed ID: 17269845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing patient assistance program use and patient responsiveness to specialty drug price for multiple sclerosis in a mid-size integrated health system.
    Brouwer E; Yeung K; Barthold D; Hansen R
    J Manag Care Spec Pharm; 2021 Jun; 27(6):732-742. PubMed ID: 34057391
    [No Abstract]   [Full Text] [Related]  

  • 5. In search of a corrected prescription drug elasticity estimate: a meta-regression approach.
    Gemmill MC; Costa-Font J; McGuire A
    Health Econ; 2007 Jun; 16(6):627-43. PubMed ID: 17238227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a three-tier formulary on antidepressant utilization and expenditures.
    Hodgkin D; Parks Thomas C; Simoni-Wastila L; Ritter GA; Lee S
    J Ment Health Policy Econ; 2008 Jun; 11(2):67-77. PubMed ID: 18509214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic utilization and cost-sharing for prescription drugs.
    Gibson TB; McLaughlin CG; Smith DG
    Adv Health Econ Health Serv Res; 2010; 22():195-219. PubMed ID: 20575234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How will medical savings accounts affect medical spending?
    Ozanne L
    Inquiry; 1996; 33(3):225-36. PubMed ID: 8883457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities.
    Li X; Guh D; Lacaille D; Esdaile J; Anis AH
    Health Policy; 2007 Aug; 82(3):340-7. PubMed ID: 17134787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cost sharing on physician utilization under favourable conditions for supplier-induced demand.
    Van de Voorde C; Van Doorslaer E; Schokkaert E
    Health Econ; 2001 Jul; 10(5):457-71. PubMed ID: 11466806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of khat price increases on consumption behavior - price elasticity analysis.
    El-Setouhy M; Alsanosy R; Makeen AM; Ghailan KY; Alsharqi A; Sheikh KA
    Subst Abuse Treat Prev Policy; 2019 May; 14(1):19. PubMed ID: 31088478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PRICE clinic for low-income elderly: a managed care model for implementing pharmacist-directed services.
    Stebbins MR; Kaufman DJ; Lipton HL
    J Manag Care Pharm; 2005 May; 11(4):333-41. PubMed ID: 15871644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of increased patient cost sharing on socioeconomic disparities in health care.
    Chernew M; Gibson TB; Yu-Isenberg K; Sokol MC; Rosen AB; Fendrick AM
    J Gen Intern Med; 2008 Aug; 23(8):1131-6. PubMed ID: 18443882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International experience in controlling pharmaceutical expenditure: influencing patients and providers and regulating industry - a systematic review.
    Lee IH; Bloor K; Hewitt C; Maynard A
    J Health Serv Res Policy; 2015 Jan; 20(1):52-9. PubMed ID: 25092883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
    Pauly NJ; Brown JD
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Out-of-pocket medication costs and use of medications and health care services among children with asthma.
    Karaca-Mandic P; Jena AB; Joyce GF; Goldman DP
    JAMA; 2012 Mar; 307(12):1284-91. PubMed ID: 22453569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lowering copayments: impact of simvastatin patent expiration on patient adherence.
    Sedjo RL; Cox ER
    Am J Manag Care; 2008 Dec; 14(12):813-8. PubMed ID: 19067498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Price Elasticity of cigarette smoking demand in the Philippines after the 2012 Sin Tax Reform Act.
    Cheng KJG; Estrada MAG
    Prev Med; 2020 May; 134():106042. PubMed ID: 32097751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of copay assistance on patient out-of-pocket costs and treatment rates with ALK inhibitors.
    Seetasith A; Wong W; Tse J; Burudpakdee C
    J Med Econ; 2019 May; 22(5):414-420. PubMed ID: 30729850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.